» Articles » PMID: 32584852

A Variety of Bacterial Aetiologies in the Lower Respiratory Tract at Patients with Endobronchial Tuberculosis

Overview
Journal PLoS One
Date 2020 Jun 26
PMID 32584852
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, our understanding of the elusive bacterial communities in the lower respiratory tract and their role in chronic lung disease has increased significantly. However, little is known about the respiratory microorganisms in patients with endobronchial tuberculosis (EBTB), which is a chronic inflammatory disease characterized by destruction of the tracheobronchial tree due to Mycobacterium tuberculosis (MTB) infection. We retrospectively reviewed data for histopathologically and microbiologically confirmed EBTB patients diagnosed at a tertiary referral hospital in South Korea between January 2013 and January 2019. Bacterial cultures were performed on bronchial washing from these patients at the time of EBTB diagnosis. A total of 216 patients with EBTB were included in the study. The median age was 73 years and 142 (65.7%) patients were female. Bacteria were detected in 42 (19.4%) patients. Additionally, bacterial co-infection was present in 6 (2.8%) patients. Apart from MTB, the most common microorganisms identified were Staphylococcus aureus (n = 14, 33.3%) followed by Klebsiella species (n = 12, 28.6%; 10 Klebsiella pneumoniae, 2 Klebsiella oxytoca), Streptococcus species (n = 5, 11.9%), Enterobacter species (n = 4, 9.5%), and Pseudomonas aeruginosa (n = 3, 7.1%). A variety of microorganisms were isolated from the bronchial washing indicating that changes in microorganism composition occur in the airways of patients with EBTB. Further studies are needed to investigate the clinical significance of this finding.

Citing Articles

Miliary Tuberculosis Associated with Klebsiella pneumonia: Managing the Double Whammy of Antimicrobial Resistance.

Mishra P, Kondisetti M, Patil A, Sarangdhar N, Gupta V Tuberc Respir Dis (Seoul). 2024; 88(1):190-192.

PMID: 39474733 PMC: 11704727. DOI: 10.4046/trd.2024.0105.


Exploring the Association of Bacterial Coinfections with Clinical Characteristics of Patients with Nontuberculous Mycobacterial Pulmonary Disease.

Moon S, Cho H, Shin B Tuberc Respir Dis (Seoul). 2024; 87(4):505-513.

PMID: 39362831 PMC: 11468447. DOI: 10.4046/trd.2024.0003.


Prevalence of Co-infection of Culture-Proven Bacterial Pathogens in Microbiologically Confirmed Pulmonary Tuberculosis Patients From a Tertiary Care Center.

Bir R, Ranjan R, Gunasekaran J, Chatterjee K, Karteeka D, Rai A Cureus. 2024; 16(8):e66482.

PMID: 39247035 PMC: 11380723. DOI: 10.7759/cureus.66482.


Impact of Respiratory Bacterial Findings on Patients with Chronic Pulmonary Aspergillosis.

Cho H, Moon S, Kim H, Shin B Int J Microbiol. 2024; 2024:1329884.

PMID: 38716459 PMC: 11074846. DOI: 10.1155/2024/1329884.


Assessing the risk of concurrent mycoplasma pneumoniae pneumonia in children with tracheobronchial tuberculosis: retrospective study.

Liu L, Jiang J, Wu L, Zeng D, Yan C, Liang L PeerJ. 2024; 12:e17164.

PMID: 38560467 PMC: 10979740. DOI: 10.7717/peerj.17164.


References
1.
Wang J, Li H, Zhang F, Ning W . Systemic inflammation and the effects of short-term antibiotic treatment for PPM positive patients with stable COPD. Int J Chron Obstruct Pulmon Dis. 2019; 14:1923-1932. PMC: 6711567. DOI: 10.2147/COPD.S217971. View

2.
Lee J, Park S, Lee D, Shin D, Yang S, Yoo B . Endobronchial tuberculosis. Clinical and bronchoscopic features in 121 cases. Chest. 1992; 102(4):990-4. DOI: 10.1378/chest.102.4.990. View

3.
Hugle T . Immunology of fibrotic lung disease: managing infections whilst preventing autoimmunity?. J Inflamm Res. 2011; 4:21-7. PMC: 3218744. DOI: 10.2147/JIR.S10602. View

4.
Shimazaki T, Taniguchi T, Saludar N, Gustilo L, Kato T, Furumoto A . Bacterial co-infection and early mortality among pulmonary tuberculosis patients in Manila, The Philippines. Int J Tuberc Lung Dis. 2018; 22(1):65-72. DOI: 10.5588/ijtld.17.0389. View

5.
Tunney M, Einarsson G, Wei L, Drain M, Klem E, Cardwell C . Lung microbiota and bacterial abundance in patients with bronchiectasis when clinically stable and during exacerbation. Am J Respir Crit Care Med. 2013; 187(10):1118-26. PMC: 3734618. DOI: 10.1164/rccm.201210-1937OC. View